104 related articles for article (PubMed ID: 10224306)
1. Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms.
Pasternak KR; Rossi GC; Zuckerman A; Pasternak GW
Brain Res; 1999 May; 826(2):289-92. PubMed ID: 10224306
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
3. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
[TBL] [Abstract][Full Text] [Related]
4. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
5. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
6. Peripheral kappa 1-opioid receptor-mediated analgesia in mice.
Kolesnikov Y; Jain S; Wilson R; Pasternak GW
Eur J Pharmacol; 1996 Aug; 310(2-3):141-3. PubMed ID: 8884210
[TBL] [Abstract][Full Text] [Related]
7. Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.
Chiu YT; Chen C; Yu D; Schulz S; Liu-Chen LY
Mol Pharmacol; 2017 Nov; 92(5):588-600. PubMed ID: 28893975
[TBL] [Abstract][Full Text] [Related]
8. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
9. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY
J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926
[TBL] [Abstract][Full Text] [Related]
10. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
Zhao Y; Joshi AA; Aldrich JV; Murray TF
Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
[TBL] [Abstract][Full Text] [Related]
11. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
[TBL] [Abstract][Full Text] [Related]
12. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
[TBL] [Abstract][Full Text] [Related]
14. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
Schindler AG; Li S; Chavkin C
Neuropsychopharmacology; 2010 Aug; 35(9):1932-42. PubMed ID: 20445500
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
Wang G; Wang H; Yang Y; Wong TM
Eur J Pharmacol; 2004 Sep; 498(1-3):53-8. PubMed ID: 15363975
[TBL] [Abstract][Full Text] [Related]
17. Role of dynorphin in hypoxic pulmonary hypertension.
Li J; Liang X; Zhou Y; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Wang Y; Liu M; Pei J
Eur J Pharmacol; 2016 Nov; 791():78-84. PubMed ID: 27568355
[TBL] [Abstract][Full Text] [Related]
18. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
[TBL] [Abstract][Full Text] [Related]
19. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
Bruchas MR; Yang T; Schreiber S; Defino M; Kwan SC; Li S; Chavkin C
J Biol Chem; 2007 Oct; 282(41):29803-11. PubMed ID: 17702750
[TBL] [Abstract][Full Text] [Related]
20. Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.
Zhang Q; Gallo RV
Endocrine; 2002 Jun; 18(1):27-32. PubMed ID: 12166621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
